QNRX
Price
$0.32
Change
-$0.01 (-3.03%)
Updated
Feb 21 closing price
Capitalization
2.61M
WVE
Price
$11.13
Change
-$0.20 (-1.77%)
Updated
Feb 21 closing price
Capitalization
1.7B
4 days until earnings call
Ad is loading...

QNRX vs WVE

Header iconQNRX vs WVE Comparison
Open Charts QNRX vs WVEBanner chart's image
Quoin Pharmaceuticals
Price$0.32
Change-$0.01 (-3.03%)
Volume$579.07K
Capitalization2.61M
Wave Life Sciences
Price$11.13
Change-$0.20 (-1.77%)
Volume$798.25K
Capitalization1.7B
QNRX vs WVE Comparison Chart
Loading...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QNRX vs. WVE commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNRX is a Hold and WVE is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (QNRX: $0.32 vs. WVE: $11.13)
Brand notoriety: QNRX and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QNRX: 15% vs. WVE: 89%
Market capitalization -- QNRX: $2.61M vs. WVE: $1.7B
QNRX [@Biotechnology] is valued at $2.61M. WVE’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNRX’s FA Score shows that 2 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • QNRX’s FA Score: 2 green, 3 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, QNRX is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNRX’s TA Score shows that 5 TA indicator(s) are bullish while WVE’s TA Score has 5 bullish TA indicator(s).

  • QNRX’s TA Score: 5 bullish, 3 bearish.
  • WVE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both QNRX and WVE are a good buy in the short-term.

Price Growth

QNRX (@Biotechnology) experienced а +3.55% price change this week, while WVE (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

QNRX is expected to report earnings on Nov 09, 2023.

WVE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.7B) has a higher market cap than QNRX($2.61M). WVE YTD gains are higher at: -10.024 vs. QNRX (-50.930). QNRX has higher annual earnings (EBITDA): -8.55M vs. WVE (-143.36M). WVE has more cash in the bank: 311M vs. QNRX (10.3M). QNRX has less debt than WVE: QNRX (6.21M) vs WVE (27.2M). WVE has higher revenues than QNRX: WVE (53.6M) vs QNRX (0).
QNRXWVEQNRX / WVE
Capitalization2.61M1.7B0%
EBITDA-8.55M-143.36M6%
Gain YTD-50.930-10.024508%
P/E RatioN/AN/A-
Revenue053.6M-
Total Cash10.3M311M3%
Total Debt6.21M27.2M23%
FUNDAMENTALS RATINGS
QNRX vs WVE: Fundamental Ratings
QNRX
WVE
OUTLOOK RATING
1..100
482
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9638
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNRX's Valuation (15) in the Biotechnology industry is somewhat better than the same rating for WVE (73). This means that QNRX’s stock grew somewhat faster than WVE’s over the last 12 months.

WVE's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as QNRX (100). This means that WVE’s stock grew similarly to QNRX’s over the last 12 months.

QNRX's SMR Rating (98) in the Biotechnology industry is in the same range as WVE (100). This means that QNRX’s stock grew similarly to WVE’s over the last 12 months.

WVE's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for QNRX (96). This means that WVE’s stock grew somewhat faster than QNRX’s over the last 12 months.

QNRX's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for WVE (100). This means that QNRX’s stock grew significantly faster than WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNRXWVE
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 6 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SQCBX13.30-0.19
-1.41%
X-Square Balanced Fund, LLC C
AUUCX19.60-0.30
-1.51%
AB Select US Equity C
JAENX143.24-2.26
-1.55%
Janus Henderson Enterprise T
TWDAX17.20-0.31
-1.77%
Templeton World Adv
HSPGX22.87-0.79
-3.34%
Emerald Growth A

QNRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with ATNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
-4.06%
ATNM - QNRX
35%
Loosely correlated
-4.88%
ATNF - QNRX
29%
Poorly correlated
-2.34%
MRNA - QNRX
28%
Poorly correlated
+5.34%
WVE - QNRX
27%
Poorly correlated
-1.77%
AADI - QNRX
26%
Poorly correlated
-2.45%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-1.77%
PRQR - WVE
53%
Loosely correlated
-0.78%
KRRO - WVE
46%
Loosely correlated
-8.24%
ATNF - WVE
39%
Loosely correlated
-2.34%
KYMR - WVE
38%
Loosely correlated
-1.63%
VYGR - WVE
37%
Loosely correlated
-0.94%
More